Visium Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Visium Asset Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-25,841	Closed	-$3.82M	–	181
2016 Q2	$3.82M	Sell	25,841 -129,075	-83%	-$19.1M	0.27%	106
2016 Q1	$21.9M	Buy	154,916 +54,916	+55%	+$7.36M	0.37%	61
2015 Q4	$14.2M	Buy	+100,000	New	+$13.3M	0.21%	111
2015 Q3	–	Sell	-4,200	Closed	-$545K	–	1174
2015 Q2	$545K	Sell	4,200 -1,800	-30%	-$235K	0.01%	620
2015 Q1	$806K	Sell	6,000 -79,854	-93%	-$10.3M	0.01%	558
2014 Q4	$10.8M	Buy	85,854 +25,154	+41%	+$3.06M	0.15%	117
2014 Q3	$7.39M	Sell	60,700 -207,198	-77%	-$25.2M	0.11%	193
2014 Q2	$31.6M	Sell	267,898 -21,336	-7%	-$2.51M	0.49%	35
2014 Q1	$34.8M	Buy	289,234 +189,012	+189%	+$22.5M	0.56%	29
2013 Q4	$11.2M	Buy	100,222 +97,422	+3,479%	+$9.69M	0.22%	90
2013 Q3	$258K	Buy	+2,800	New	+$253K	0.01%	669

Other funds holding TMO

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Visium Asset Management's TMO Position: Q3 2016 in Review

Visium Asset Management sold out of Thermo Fisher Scientific (TMO) in Q3 2016, closing a stake of 25,841 shares — an estimated $3.82M sold.

Visium Asset Management first reported a position in TMO in Q3 2013 and held it in 11 quarters. The position peaked at $34.8M in Q1 2014. 1,045 funds tracked by Wall St. Rank hold TMO as of Q3 2016.

Visium Asset Management reported no remaining Thermo Fisher Scientific position as of Q3 2016 after selling out during the quarter.
Visium Asset Management sold 25,841 Thermo Fisher Scientific shares in Q3 2016, an estimated $3.82M.
Visium Asset Management first reported a position in Thermo Fisher Scientific in Q3 2013 and held it in 11 quarters.
Visium Asset Management's Thermo Fisher Scientific position peaked at $34.8M in Q1 2014.
1,045 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2016.

Based on Visium Asset Management's 13F filing for Q3 2016.